Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease.

Subjects

Subjects :

Humans
Female
Male
Adult
Middle Aged
Treatment Outcome
Biological Therapy methods
Remission Induction
Heterocyclic Compounds, 3-Ring administration & dosage
Heterocyclic Compounds, 3-Ring therapeutic use
Inflammatory Bowel Diseases drug therapy
Drug Therapy, Combination

Details

Language :

English

ISSN :

1536-4844

Volume :

30

Issue :

10

Database :

MEDLINE

Journal :

Inflammatory bowel diseases

Publication Type :

Academic Journal

Accession number :

38767984

Full Text :

https://doi.org/10.1093/ibd/izae105